Artículos de revistas
Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation
Fecha
2015-02Registro en:
Ahmad, Shakil; Hewett, Peter W.; Fujisawa, Takeshi; Sissaoui, Samir; Cai, Meng; et al.; Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation; Schattauer Gmbh-Verlag Medizin Naturwissenschaften; Thrombosis and Haemostasis; 113; 2; 2-2015; 329-337
0340-6245
CONICET Digital
CONICET
Autor
Ahmad, Shakil
Hewett, Peter W.
Fujisawa, Takeshi
Sissaoui, Samir
Cai, Meng
Gueron, Geraldine
Al Ani, Bahjat
Cudmore, Melissa
Faraz Ahmed, S.
Wong, Michael K. K.
Wegiel, Barbara
Otterbein, Leo E.
Vítek, Libor
Ramma, Wenda
Wang, Keqing
Ahmed, Asif
Resumen
Carbon monoxide (CO) is a gaseous autacoid known to positively regulate vascular tone; however, its role in angiogenesis is unknown. The aim of this study was to investigate the effect of CO on angiogenesis and vascular endothelial growth factor (VEGF) receptor-2 phosphorylation. Human umbilical vein endothelial cells (HUVECs) were cultured on growth factor- reduced Matrigel and treated with a CO-releasing molecule (CORM-2) or exposed to CO gas (250 ppm). Here, we report the surprising finding that exposure to CO inhibits vascular endothelial growth factor (VEGF)-induced endothelial cell actin reorganisation, cell proliferation, migration and capillary-like tube formation. Similarly, CO suppressed VEGF-mediated phosphorylation of VEGFR-2 at tyrosine residue 1175 and 1214 and basic fibroblast growth factor- (FGF-2) and VEGF-mediated Akt phosphorylation. Consistent with these data, mice exposed to 250 ppm CO (1h/day for 14 days) exhibited a marked decrease in FGF-2-induced Matrigel plug angiogenesis (p<0.05). These data establish a new biological function for CO in angiogenesis and point to a potential therapeutic use for CO as an anti-angiogenic agent in tumour suppression.